| Dr. Jai Maharaj 2005-03-26, 10:21 am |
| Forwarded message from anon@mouse.com
[ Subject: Abbott Pulls "ADHD" Drug from Market
[ From: anon@mouse.com
[ Date: 25 Mar 2005 13:50:24 -0600
DRUG NEWS FLASH 'ADHD'-stimulant drug Cylert (pemoline) taken off
market by Abbott
see excerpt below re Cylert and other stimulants prescribed to kids
by Peter Breggin & David Cohen in YOUR DRUG MAY BE YOUR PROBLEM:
"We are appalled by the widespread use of stimulants to control and
suppress the behavior of children diagnosed with ADHD. The aim is
to correct behavior described in terms of hyperactivity, impulsivity,
and inattention. In actuality, however, stimulants subdue behaviour
by impairing mental function, they often cause the very problems
they are supposed to correct." (1999, p.65) Don
http://www.chron.com/cs/CDA/ssistory.mpl/nation/3101421 March 24,
2005, 8:08PM
Attention deficit drug being pulled from market
Maker doesn't address charges of liver failure
Reuters News Service
WASHINGTON - Abbott Laboratories said Thursday it was halting sales
of a 30-year-old attention deficit drug that a consumer group
complained was too dangerous to stay on the market.
Abbott decided to discontinue the drug, Cylert, because of declining
sales, Abbott spokeswoman Melissa Brotz said. The drug's sales this
year will be less than $1 million, she said.
Brotz declined to comment on charges made earlier Thursday from
consumer group Public Citizen that the drug had caused 21 cases of
liver failure, including 13 that were fatal or required transplants.
"We're in the process of discontinuing it ... but that's because
of declining usage and sales and because there are generics
available," Brotz said.
Generic companies sell copycat versions of the drug under the name
pemoline.
Public Citizen asked the U.S. Food and Drug Administration on
Thursday to ban Cylert and its generic competitors immediately.
Generic companies can still sell their versions even after Abbott
pulls the medicine, unless the FDA determines the drug was withdrawn
for safety reasons.
A petition from Public Citizen said Britain and Canada already had
pulled the drug off the market, while the FDA opted to strengthen
warnings twice and allow sales to continue.
The warnings failed to increase doctors' monitoring of liver function
in patients treated with pemoline, which offers no benefit over
other therapies, the group said.
"In light of this evidence of unique liver toxicity without evidence
of unique therapeutic benefit, we contend that the only responsible
course of action is to remove this dangerous drug from the market,"
Public Citizen said.
Cylert is a stimulant that was approved to treat attention deficit
hyperactivity disorder, or ADHD, in 1975. Last year, about 117,000
prescriptions for the drug were filled in the United States,
according to Public Citizen.
FDA spokeswoman Susan Cruzan said the agency would carefully review
the petition, which also was signed by Dr. Fredric Solomon, a
psychiatrist and ADHD specialist at the George Washington University
School of Medicine.
Public Citizen has filed several petitions with the FDA seeking to
have various drugs withdrawn.
Earlier this month, the FDA denied a petition from Public Citizen
asking for a ban on AstraZeneca's cholesterol treatment Crestor.
End of forwarded message from anon@mouse.com
Jai Maharaj
http://www.mantra.com/jai
Om Shanti
Hindu Holocaust Museum
http://www.mantra.com/holocaust
Hindu life, principles, spirituality and philosophy
http://www.hindu.org
http://www.hindunet.org
The truth about Islam and Muslims
http://www.flex.com/~jai/satyamevajayate
The terrorist mission of Jesus stated in the Christian bible:
"Think not that I am come to send peace on earth: I came not so send
peace, but a sword.
"For I am come to set a man at variance against his father, and the
daughter against her mother, and the daughter in law against her mother in
law.
"And a man's foes shall be they of his own household.
- Matthew 10:34-36.
o Not for commercial use. Solely to be fairly used for the educational
purposes of research and open discussion. The contents of this post may not
have been authored by, and do not necessarily represent the opinion of the
poster. The contents are protected by copyright law and the exemption for
fair use of copyrighted works.
o If you send private e-mail to me, it will likely not be read,
considered or answered if it does not contain your full legal name, current
e-mail and postal addresses, and live-voice telephone number.
o Posted for information and discussion. Views expressed by others are
not necessarily those of the poster who may or may not have read the article.
FAIR USE NOTICE: This article may contain copyrighted material the use of
which may or may not have been specifically authorized by the copyright
owner. This material is being made available in efforts to advance the
understanding of environmental, political, human rights, economic,
democratic, scientific, social, and cultural, etc., issues. It is believed
that this constitutes a 'fair use' of any such copyrighted material as
provided for in section 107 of the US Copyright Law. In accordance with Title
17 U.S.C. Section 107, the material on this site is distributed without
profit to those who have expressed a prior interest in receiving the included
information for research, comment, discussion and educational purposes by
subscribing to USENET newsgroups or visiting web sites. For more information
go to: http://www.law.cornell.edu/uscode/17/107.shtml
If you wish to use copyrighted material from this article for purposes of
your own that go beyond 'fair use', you must obtain permission from the
copyright owner.
Since newsgroup posts are being removed
by forgery by one or more net terrorists,
this post may be reposted several times.
|